EDGAR Filing Documents for 0001104659-18-016770

Form 8-K - Current report:

SEC Accession No. 0001104659-18-016770

Filing Date

2018-03-13

Accepted

2018-03-12 17:42:24

Documents

Period of Report

2018-03-07

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a18-8090_18k.htm	8-K	38935
2	EX-3.1	a18-8090_1ex3d1.htm	EX-3.1	50860
3	EX-3.2	a18-8090_1ex3d2.htm	EX-3.2	142612
4	EX-10.1	a18-8090_1ex10d1.htm	EX-10.1	95764
5	EX-99.1	a18-8090_1ex99d1.htm	EX-99.1	8774
6	EX-99.2	a18-8090_1ex99d2.htm	EX-99.2	7336
	Complete submission text file	0001104659-18-016770.txt		345598

Mailing Address 780 EAST MAIN STREET BRANFORD CT 06405

Business Address 780 EAST MAIN STREET BRANFORD CT 06405 203-643-8060

BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)